-
UK Chancellor Rachel Reeves is set to announce her second budget amid economic challenges, including rising unemployment and a shrinking jobs market. She signals potential tax hikes, breaking previous manifesto promises, to address a significant fiscal deficit and fund public services, with a focus on fairness and economic stability.
-
As of late November 2025, the US, UK, Canada, and Japan face an early, severe flu season driven by the H3N2 subclade K variant, which has mutated beyond current vaccine strains. Hospital admissions and flu cases, especially among children and vulnerable groups, are rising. Concurrently, norovirus infections are doubling nationwide, with health officials urging hygiene and vaccination to mitigate risks.
-
A study published in Nature Medicine reports the first direct measurements of brain activity in a person taking tirzepatide, a drug used for diabetes and weight loss. The findings suggest potential for GLP-1 drugs in treating eating disorders, but effects appear temporary and limited to specific brain regions.
-
The UK government announced sweeping changes to immigration and asylum policies, including longer settlement wait times, stricter eligibility criteria, and temporary refugee status. High earners and NHS workers are fast-tracked, while others face waits up to 30 years. The reforms aim to control migration and reform public services.
-
Prime Minister Keir Starmer defended recent government measures, including a £26 billion tax hike and welfare reforms, amid criticism over economic forecasts and policy decisions. Opposition leader Keir Starmer accused the government of misleading the public and emphasized the importance of welfare and economic stability. The story highlights ongoing political and economic tensions in the UK.
-
The UK National Screening Committee is set to recommend targeted prostate cancer screening for high-risk groups, including men with BRCA mutations and Black men, amid ongoing debates over PSA test efficacy and potential harms of mass screening. The decision follows recent advocacy and new research trials.
-
Recent articles highlight NHS pressures from rising emergency visits for minor ailments, staff strikes, and high hospital occupancy. Meanwhile, stories of individual health crises, including cancer diagnoses and organ transplants, underscore ongoing challenges in patient care and medical decision-making. The stories reveal systemic issues and personal resilience.
-
Fifty children from Gaza, affected by ongoing Israeli strikes, have been evacuated to the UK for treatment. Prince William visited children receiving care, expressing admiration for their courage amid the conflict. UK officials emphasize scaling aid into Gaza post-ceasefire.
-
The UK and US have agreed to a trade deal that maintains 0% import taxes on medicines for three years, while increasing the NHS's drug spending threshold by 25%. The deal aims to boost investment, protect jobs, and facilitate access to innovative medicines, amid ongoing industry concerns over investment and pricing practices.
-
A UK-led trial is testing whether Aquablation, a robotic waterjet therapy, can treat localized prostate cancer as effectively as traditional surgery, with fewer side effects. The trial involves seven countries and aims to improve quality of life for patients.
-
On Christmas Eve, UK political leaders and public figures urged citizens to show kindness and support to those in need. Keir Starmer emphasized reaching out to vulnerable neighbors, while leaders highlighted community spirit amid economic challenges and ongoing social issues.
-
A human error at Glasgow's Queen Elizabeth University Hospital led to the wrongful release and cremation of a body, causing distress to two families. NHS Greater Glasgow and Clyde has suspended staff and launched an investigation, offering support to those affected.
-
Nestlé has recalled specific batches of its infant formulas globally, including South Africa, due to potential contamination with cereulide toxin, which can cause nausea, vomiting, and cramps in infants. No illnesses have been reported, but parents are advised to check batch numbers and seek medical advice if concerned.
-
The UK government has made multiple policy U-turns this week, including support for pubs, welfare, and business rates, citing listening to public feedback. Critics see these as signs of indecision amid ongoing economic pressures, while officials frame them as responsive governance.
-
Recent reports reveal illegal sunbed use among children in the UK, despite laws banning under-18s. Authorities plan to strengthen enforcement, including banning unsupervised sessions and mandatory ID checks, amid rising skin cancer risks linked to UV exposure. New proposals aim to better protect youth from carcinogenic risks.
-
Multiple UK local authorities, including Birmingham, Worcestershire, and Scottish councils, are grappling with severe financial challenges. They plan significant council tax hikes, service cuts, and debt management strategies amid ongoing budget shortfalls, social care costs, and systemic funding issues, raising concerns about local service sustainability.
-
The UK government has announced a comprehensive 10-year cancer strategy aiming for 75% of patients to be cancer-free or living well after five years by 2035. The plan includes ambitious targets for diagnosis, treatment, and technological innovation, but faces significant hurdles due to workforce shortages and reliance on unproven technologies. Recent data shows current treatment delays and rising early-onset cancers threaten progress.
-
The FDA refused to approve Moderna's new flu vaccine after criticizing trial design and comparator choice. The decision follows increased scrutiny of mRNA vaccines under Health Secretary Kennedy's policies, with Moderna planning to meet with regulators to clarify next steps.
-
Researchers from Oxford's Newrotex have developed a silk-based nerve repair technology using spider silk from Madagascar. Preliminary tests show promising results for treating nerve damage, potentially replacing current autograft procedures. Target commercial availability is set for 2027, pending further trials.